Database: Ovid MEDLINE(R) and Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Daily and Versions(R) <1946 to November 21, 2019> 
Search Strategy:
--------------------------------------------------------------------------------
1     Arthritis, Rheumatoid/ 
2     ((rheumatoid adj2 arthrit$) or (rheumatoid adj2 arthros$)).tw,kw. 
3     Rheumatoid nodule/ or (rheumatoid adj2 nodule$).tw,kw. 
4     or/1-3 
5     Hydroxychloroquine/ or (hydroxychloroquine or Plaquenil).tw,kw. 
6     (leflunomide or Arava).tw,kw. 
7     Methotrexate/ or (methotrexate or Rheumatrex or Trexall or Otrexup or Rasuvo).tw,kw. 
8     Sulfasalazine/ or (sulfasalazine$ or sulphasalazine$ or Azulfidine).tw,kw. 
9     or/5-8 [conventional synthetic DMARDs] 
10     Adalimumab/ or (adalimumab or Humira).tw,kw. 
11     Certolizumab Pegol/ or (certolizumab or Cimzia).tw,kw. 
12     Etanercept/ or (etanercept or Enbrel).tw,kw. 
13     (Golimumab or Simponi).tw,kw. 
14     Infliximab/ or (infliximab or Remicade).tw,kw. 
15     Tumor Necrosis Factor-alpha/tu [Therapeutic Use] 
16     Receptors, Tumor Necrosis Factor/tu 
17     ((tumor or tumour) adj necrosis factor adj (block$ or inhibitor$)).tw. or (TNF inhibitor$ or TNFi).tw,kw. or (anti-TNF or anti TNF).tw,kw. 
18     Abatacept/ or (abatacept or Orencia).tw,kw. 
19     Rituximab/ or (rituximab or Rituxan or MabThera or Remsima).tw,kw. 
20     Antibodies, Monoclonal/tu 
21     (Sarilumab or Kevzara).tw,kw. 
22     tocilizumab.tw,kw. 
23     Interleukin-6/tu or Interleukin-1/tu or Receptors, Interleukin-6/tu or Receptors, Interleukin-1/tu 
24     (interleukin 6 inhibit$ or IL 6 inhibit$).tw,kw. 
25     biologic$ DMARD$.tw,kw. 
26     biological products/ and exp antirheumatic agents/ 
27     or/10-26 [biological DMARDs] 
28     (Amjevita or "adalimumab-atto").tw,kw. 
29     (Erelzi or "etanercept szzs").tw,kw.
30     (infliximab-QBTZ or Ixifi).tw,kw. 
31     ("Infliximab-DYBB" or Inflectra).tw,kw. 
32     biosimilar pharmaceuticals/ and antirheumatic agents/ 
33     (biosimilar adj2 disease adj2 modifying adj2 anti-rheumatic$).tw,kw. 
34     (biosimilar adj3 DMARD$).tw,kw. 
35     (bs adj DMARD$).tw,kw. 
36     or/28-35 [biosimiar dmards] 
37     (baricitinib or Olumiant).tw,kw. 
38     (fostamatanib or Tavalisse).tw,kw. 
39     (Filgotinib or GS-6034 or GLPG0634).tw,kw. 
40     (tofacitinib or tasocitinib or Xeljanz or cp690550 or "cp 690550" or "cp 690 550" or Upadacitinib or “ABT-494”).tw,kw. 
41     (((JAK 1 or JAK 2) adj inhibit$) or (Janus kinase 1 inhibit$ or Janus kinase 3 inhibit$)).tw,kw. 
42     Janus Kinase inhibitors/ or Janus Kinase 1/ai or Janus Kinase 3/ai 
43     or/37-42 [targeted dmards]
44     4 and (9 or 27 or 36 or 43) [PICO 1-11,16-20,24-27,52-54,56-60-63] 